Results 161 to 170 of about 283,903 (204)
Some of the next articles are maybe not open access.
2010
Pulmonary embolism is a complication of venous thrombosis. It is a major cause of morbidity and mortality, but a condition that is highly preventable and, when diagnosed, very effectively treated. Yet in the United States, more people die of pulmonary embolism each year than of AIDS. The clinician must maintain a high index of suspicion at all times in
openaire +2 more sources
Pulmonary embolism is a complication of venous thrombosis. It is a major cause of morbidity and mortality, but a condition that is highly preventable and, when diagnosed, very effectively treated. Yet in the United States, more people die of pulmonary embolism each year than of AIDS. The clinician must maintain a high index of suspicion at all times in
openaire +2 more sources
Prevention of Venous Thromboembolism
Chest, 2001Venous thromboembolism (VTE) refers to the presence of either a deep venous thrombosis (DVT), pulmonary embolism (PE), or both. Thrombosis generally begins in the deep veins of the lower extremities (DVT); over time, a thrombus may embolize to the pulmonary vasculature and cause a PE.
W H, Geerts +6 more
openaire +2 more sources
Treatment of Venous Thromboembolism
Thrombosis and Haemostasis, 1999IntroductionVenous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common clinical problem. If untreated or inadequately treated, there is a high risk of fatal PE1 and recurrent venous thrombosis.2-4 The objectives of treatment are to prevent local extension of thrombus, embolization, and recurrent ...
S M, Bates, J, Hirsh
openaire +2 more sources
Treatment of venous thromboembolism
International Journal of Hematology, 2000The combination of heparin and oral anticoagulants has been the treatment of choice for most patients with venous thromboembolism in the last two decades. Heparin has been proven to be effective when administered by intravenous continuous infusion or by subcutaneous injection. Oral anticoagulants should be started at the same time and heparin should be
openaire +5 more sources
Hyperhomocysteinemia and Venous Thromboembolism
Seminars in Thrombosis and Hemostasis, 2006Homocysteine (Hcy) is a sulfhydryl amino acid derived from the metabolic conversion of methionine, which is dependent on vitamins (folic acid, B12 and B6) as cofactors or cosubstrates. Severe hyperhomocysteinemia (homocystinuria), due to inherited metabolic defects of Hcy metabolism, is associated with very high risk of venous thromboembolism (VTE ...
openaire +2 more sources
Current Opinion in Cardiology, 1991
During the past year, the findings of several clinical trials have been published that have important implications for the care of patients with venous thromboembolism. These clinical trials have produced advances in the diagnosis and treatment of venous thrombosis and pulmonary embolism and in the prevention of venous thromboembolism in high-risk ...
R D, Hull, G E, Raskob
openaire +2 more sources
During the past year, the findings of several clinical trials have been published that have important implications for the care of patients with venous thromboembolism. These clinical trials have produced advances in the diagnosis and treatment of venous thrombosis and pulmonary embolism and in the prevention of venous thromboembolism in high-risk ...
R D, Hull, G E, Raskob
openaire +2 more sources
Treatment of Venous Thromboembolism
Cardiology in Review, 2002Venous thromboembolism (VTE), comprised of pulmonary embolism (PE) and deep vein thrombosis (DVT), is a disease entity with a significant morbidity and mortality. Anticoagulation, initially with intravenous heparin and followed with long term warfarin treatment is the traditional therapy for VTE.
Roderick, Nazario +2 more
openaire +2 more sources
Controversies in Venous Thromboembolism
Critical Care Nursing Quarterly, 2017Numerous controversies exist in the diagnosis of venous thromboembolism despite all the guidelines that are currently available. Screening of malignancy in venous thromboembolism has been a debated issue, as it has not been shown to change mortality.
Suman, Yadam +3 more
openaire +2 more sources
Cancer and venous thromboembolism
American Heart Journal, 1996Neoplastic cells can activate the clotting system directly, thereby generating thrombin, or indirectly, by stimulating mononuclear cells to synthesize and express various procoagulants. Clinical manifestations of increased thrombin generation may be accentuated by down-regulation of endothelial cell counterregulatory mechanisms, such as decreased ...
A, Piccioli +3 more
openaire +2 more sources
Pregnancy and venous thromboembolism
Current Opinion in Obstetrics & Gynecology, 2014This review provides a concise and complete overview of diagnostic work-up and treatment of venous thromboembolism in pregnancy, with attention to recent research developments and recent applicable guidelines. This may be useful for all the players of the multidisciplinary interaction needed in this disease management, namely cardiologists and ...
Ralli E, Zezza L, Caserta D.
openaire +2 more sources